research

New Data Indicates Imatinib Boosts Long-Term Survival for Some GIST Patients

A significant finding from a newly published study in JAMA Oncology, indicates that nearly one-fourth of GIST patients with advanced disease initially treated with imatinib will survive for ten years or more. The study, [...]

By |2018-10-30T09:19:32-04:00February 27th, 2017|News, Research|

Columbia University Medical Center, NewYork-Presbyterian and The Life Raft Group, a Non-profit, Announce Innovative Partnership to Accelerate Cancer Research

New York, NY and Wayne, NJ - January 12, 2017 Columbia University Medical Center, NewYork-Presbyterian and the Life Raft Group (LRG), a patient advocacy organization specializing in GIST cancer, announced today that they have [...]

By |2021-03-04T11:01:59-05:00January 12th, 2017|News, Research|

Quadruple-Negative GIST Tumors May Be More Likely To Harbor NF1 Mutations As Well

In a pre-print electronic publication of the July 7, 2016 edition of Clinical Cancer Research, a team of Italian researchers examined the link between “Quadruple-Negative” GISTs (those that do not exhibit KIT, PDGFRA, or BRAF [...]

By |2018-10-30T09:41:06-04:00July 19th, 2016|Clinical Trials, News, Research|

How to be a GIST Hero: Donating Tissue for GIST Research

For  patients who have recently been diagnosed with cancer, donating a tissue sample is probably the last thing on their minds. But it’s an important consideration. Researchers often rely on donated tissue to advance [...]

By |2018-10-30T09:49:49-04:00June 10th, 2016|Newsletter, Research, Tissue Bank|
Go to Top